JNJ-54452840

DRUG3 trials

Sponsors

Janssen Research & Development, LLC

Conditions

HealthyHeart Failure

Phase 1

To Assess the Pharmacokinetics and Safety of Single Doses of JNJ-54452840 in Healthy Japanese and Caucasian Participants

CompletedNCT01809353

Janssen Research & Development, LLCHealthy

Start: 2013-07-31End: 2014-09-30Updated: 2015-03-23

A Crossover Study to Evaluate the Effect of JNJ-54452840 on Pharmacodynamics of Metoprolol Tartrate Immediate-Release in Healthy Participants

WithdrawnNCT01902550

Janssen Research & Development, LLCHealthy

Start: 2013-07-31End: 2014-05-31Updated: 2016-11-01

Phase 2

A Study to Assess the Pharmacokinetics and Pharmacodynamics of JNJ-54452840 in Participants With Heart Failure and Anti-beta1-adrenergic Receptor Autoantibodies

WithdrawnNCT01798745

Janssen Research & Development, LLCHeart Failure

Start: 2014-11-30End: 2015-12-31Updated: 2014-04-09